Zhejiang Shengda Bio-Pharm Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 450.438 million compared to CNY 250.931 million a year ago. Operating income was CNY 177.916 million compared to CNY 37.305 million a year ago. Net income was CNY 151.428 million compared to CNY 33.982 million a year ago. Basic earnings per share from continuing operations was CNY 0.9 compared to CNY 0.22 a year ago. Diluted earnings per share from continuing operations was CNY 0.86 compared to CNY 0.22 a year ago.